article thumbnail

Bioavailability Enhancement Technologies

Roots Analysis

Moreover, it is a well-established fact that the systemic / local absorption and distribution of a therapeutic intervention is directly proportional to its bioavailability. Technology evaluation framework provides a value addition matrix for bioavailability enhancement approaches currently employed by industry stakeholders.

article thumbnail

dsm-firmenich launches CBtru, revolutionizing CBD drug development with enhanced bioavailability

Outsourcing Pharma

dsm-firmenich has announced the launch of CBtru รข an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How PK Modeling Can Inform Sample Size Estimation and Dose Selection for Your Product

Camargo

Given that it can take up to 20 years for a final product to be approved, it is unsurprising that drug attrition rates are very high. Pharmacokinetics (PK) and bioequivalence (BE) studies serve as the foundation of determining the fate of drug products. Pharmacokinetic Modeling: Non-Linear Mixed Effects Modeling.

article thumbnail

Pharmanovia taps Nanoform to improve bioavailability of โ€˜iconic branded medicineโ€™

Outsourcing Pharma

The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.

article thumbnail

EverGrainโ€™s Line of Barley-Based Products Scores Upcycled Certification

XTalks

EverGrain Ingredients, a barley protein and fiber solutions company, recently received certification from the Upcycled Food Association (UFA) for its entire portfolio of products. The brand saw a unique opportunity to extract the excess barley to meet the global demand for sustainable, plant-based products. Barley Milk.

article thumbnail

Zerion and Insud to develop Dispersome formulations of drugs

Pharmaceutical Technology

Zerion Pharma has entered a partnership with Insud Pharma for the development and marketing of drug products using Zerion Pharma's solubility-boosting Dispersome technology. . The finished product dosage form, clinical development and the final productsโ€™ marketing and sales across the globe will be handled by Insud. .

article thumbnail

Betta to commercialise C4 Therapeuticsโ€™ CFT8919 in greater China

Pharmaceutical Technology

CFT8919 is an orally bioavailable BiDAC degrader designed to exhibit potent and selective activity against EGFR L858R in patients with non-small cell lung cancer (NSCLC). C4T can also earn up to $357m in milestone payments and receive low to mid-double-digit percentage royalties on net sales of the product in greater China.

In-Vivo 130